Zacks Research Issues Negative Estimate for SRPT Earnings
Sarepta Therapeutics, Inc. (NASDAQ:SRPT – Free Report) – Stock analysts at Zacks Research decreased their Q1 2027 earnings per share (EPS) estimates for shares of Sarepta Therapeutics in a note issued to investors on Tuesday, April 8th. Zacks Research analyst S. Ganoria now forecasts that the biotechnology company will earn $2.90 per share for the […]
More Stories
GRAIL (GRAL) Expected to Announce Quarterly Earnings on Tuesday
GRAIL (NASDAQ:GRAL – Get Free Report) is projected to announce its Q2 2025 earnings results after the market closes on...
Jaguar Animal Health (JAGX) to Release Earnings on Tuesday
Jaguar Animal Health (NASDAQ:JAGX – Get Free Report) is expected to be posting its Q2 2025 quarterly earnings results before...
MIRA Pharmaceuticals (MIRA) to Release Quarterly Earnings on Tuesday
MIRA Pharmaceuticals (NASDAQ:MIRA – Get Free Report) is projected to announce its earnings results before the market opens on Tuesday,...
Paysafe (PSFE) Expected to Announce Earnings on Tuesday
Paysafe (NYSE:PSFE – Get Free Report) is anticipated to post its Q2 2025 quarterly earnings results before the market opens...
Beam Global (BEEM) Projected to Post Quarterly Earnings on Tuesday
Beam Global (NASDAQ:BEEM – Get Free Report) is expected to announce its Q2 2025 earnings results before the market opens...
Adherex Technologies (FENC) to Release Earnings on Tuesday
Adherex Technologies (NASDAQ:FENC – Get Free Report) is expected to release its Q2 2025 earnings data before the market opens...